Physician profile
Ralph Franklin Rashbaum
NPI 1871520593
$616,124.80
in general payments reported to CMS, 2019-2025
13 companies · $54K in 2025
The $54K reported for 2025 was more than what 88% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134K · 2020: $134K · 2021: $28K · 2022: $129K · 2023: $80K · 2024: $57K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $189K · Consulting Fee: $2,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $188,799.32 |
| Consulting Fee | $2,700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $269,187.72 | 2019-2022 | |
| Zimvie INC. | $160,705.88 | 2022-2023 | |
| Highridge Medical LLC | $111,284.09 | 2024-2025 | Mobi-C Plug & Fit US |
| Orthofix Medical, INC. | $72,075.00 | 2020-2023 | |
| Surgalign Spine Technologies, INC. | $1,507.52 | 2019-2021 | |
| Cerapedics INC. | $357.53 | 2019 | |
| Painteq LLC | $217.22 | 2022 | |
| Stimwave Technologies Incorporated | $211.26 | 2019-2021 | |
| Si-Bone, INC. | $189.34 | 2019-2020 | |
| Stratus Medical, LLC | $142.86 | 2021 | |
| Medtronic USA, INC. | $124.10 | 2019 | |
| Nuvasive, INC. | $122.28 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$453,550.41 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Rashbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.